Outlook Therapeutics, Inc. Modification Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to At The Market Sales Agreement between Outlook Therapeutics, Inc. and BTIG, LLC (April 12, 2024)
Modification Agreements
Outlook Therapeutics, Inc.
Biotechnology
2024
Global Amendment to Secured Convertible Promissory Notes between Outlook Therapeutics, Inc. and Iliad Research and Trading, L.P. and Chicago Venture Partners, L.P.
Modification Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Agreement to Amend Series A-1 Convertible Preferred Stock between Outlook Therapeutics, Inc. and BioLexis Pte. Ltd.
Modification Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Letter Amendment to Strategic Partnership Agreement between MTTR, LLC and Outlook Therapeutics, Inc.
Modification Agreements
Outlook Therapeutics, Inc.
Biotechnology
2019
Second Note and Warrant Amendment and Waiver between Oncobiologics, Inc. and Purchasers (November 5, 2018)
Modification Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2018
First Amendment to Note and Warrant Purchase Agreement between Oncobiologics, Inc. and Purchasers
Modification Agreements
Outlook Therapeutics, Inc.
Biotechnology
2017